Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19 Immunology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Not applicableEnded earlyNCT04892797
What this trial is testing

Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients

Who this might be right for
Covid19
University of Vermont 16
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Not applicableStudy completedNCT04371835
What this trial is testing

COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings

Who this might be right for
HIV-infection/AidsCoronavirus Infection
Kirby Institute 596
Not applicableStudy completedNCT04910230
What this trial is testing

Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19

Who this might be right for
Covid19Lymphopenia
Qiang Hu 24
Not applicableStudy completedNCT04703114
What this trial is testing

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

Who this might be right for
Covid19SARS-CoV-2
Assistance Publique - Hôpitaux de Paris 57
Not applicableActive Not RecruitingNCT05220163
What this trial is testing

Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Who this might be right for
TuberculosisCOVID-19HIV Infections
University of Cape Town 26,200
Not applicableStudy completedNCT04378777
What this trial is testing

Immunophenotyping Assessment in a COVID-19 Cohort

Who this might be right for
Coronavirus Disease 2019 (COVID-19)SARS-CoV-2
National Institute of Allergy and Infectious Diseases (NIAID) 1,227
Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Not applicableUnknownNCT04421391
What this trial is testing

QuadraMune(TM) for Prevention of COVID-19

Who this might be right for
Covid19CoronavirusSARS-CoV 2
Therapeutic Solutions International 500
Not applicableStudy completedNCT05028881
What this trial is testing

COVID-19 Serology in People Living with HIV in Hong Kong

Who this might be right for
HIV InfectionsSARS-CoV-2 InfectionVaccination; Infection
Chinese University of Hong Kong 488
Testing effectiveness (Phase 2)UnknownNCT04587219
What this trial is testing

The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

Who this might be right for
Coronavirus Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Early research (Phase 1)Study completedNCT05435027
What this trial is testing

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

Who this might be right for
COVID-19SARS-CoV-2
Gritstone bio, Inc. 342
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Not applicableUnknownNCT04736524
What this trial is testing

Immune Response Following COVID-19 Vaccination

Who this might be right for
IgM and IgG in Blood
Texas Cardiac Arrhythmia Research Foundation 500
Not applicableUnknownNCT06410053
What this trial is testing

The All Ireland Infectious Diseases Cohort Project

Who this might be right for
Infectious Disease
University College Dublin 10,000
Not applicableStudy completedNCT05268380
What this trial is testing

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia

Who this might be right for
COVID-19HIV SeropositivityTuberculosis, Pulmonary+1 more
University of Namibia 1,750
Not applicableLooking for participantsNCT06762002
What this trial is testing

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Who this might be right for
ImmunologyAllergyGenetic Diseases+1 more
Institut National de la Santé Et de la Recherche Médicale, France 500
Not applicableUnknownNCT04368884
What this trial is testing

Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients

Who this might be right for
Covid-19
Max Healthcare Insititute Limited 1,000
Not applicableLooking for participantsNCT04459689
What this trial is testing

COVID-19 in PID Survey

Who this might be right for
Primary Immune DeficiencyCOVID
Imagine Institute 200
Next Page